Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 286369, 7 pages
http://dx.doi.org/10.1155/2015/286369
Research Article

Testosterone Depletion Induces Demethylation of Murine Reelin Promoter CpG Dinucleotides: A Preliminary Study

Department of Medical Genetics, School of Medical Sciences, CESED/FCM, Avenida Senador Argemiro De Figueiredo 1901, Itararé, 58411-020 Campina Grande, PB, Brazil

Received 29 July 2015; Accepted 10 September 2015

Academic Editor: Thomas O. Obisesan

Copyright © 2015 Victor Augusto Moraes da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Salomon, T. Vos, D. R. Hogan et al., “Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2129–2143, 2012. View at Publisher · View at Google Scholar
  2. O. D. Howes and R. M. Murray, “Schizophrenia: an integrated sociodevelopmental-cognitive model,” The Lancet, vol. 383, no. 9929, pp. 1677–1687, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schmitt, B. Malchow, A. Hasan, and P. Falkai, “The impact of environmental factors in severe psychiatric disorders,” Frontiers in Neuroscience, vol. 8, article 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Miyamoto, G. E. Duncan, C. E. Marx, and J. A. Lieberman, “Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs,” Molecular Psychiatry, vol. 10, no. 1, pp. 79–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. D. R. Grayson and A. Guidotti, “The dynamics of DNA methylation in schizophrenia and related psychiatric disorders,” Neuropsychopharmacology, vol. 38, no. 1, pp. 138–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Picard, I. Amado, S. Mouchet-Mages, J.-P. Olié, and M.-O. Krebs, “The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences,” Schizophrenia Bulletin, vol. 34, no. 1, pp. 155–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. U. DeSilva, G. D'Arcangelo, V. V. Braden et al., “The human reelin gene: isolation, sequencing, and mapping on chromosome 7,” Genome Research, vol. 7, no. 2, pp. 157–164, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. H. M. Abdolmaleky, K.-H. Cheng, A. Russo et al., “Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 134, no. 1, pp. 60–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Dong, R. C. Agis-Balboa, M. V. Simonini, D. R. Grayson, E. Costa, and A. Guidotti, “Reelin and glutamic acid decarboxylase67 promoter remodeling in an epeginetic methionine-induced mouse model of schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12578–12583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Pesold, W. S. Liu, A. Guidotti, E. Costa, and H. J. Caruncho, “Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 3217–3222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Teixeira, E. D. Martín, I. Sahún et al., “Overexpression of reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder,” Neuropsychopharmacology, vol. 36, no. 12, pp. 2395–2405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Beffert, E. J. Weeber, A. Durudas et al., “Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2,” Neuron, vol. 47, no. 4, pp. 567–579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Maloku, I. R. Covelo, I. Hanbauer et al., “Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4407–4411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Ovadia and S. Shifman, “The genetic variation of RELN expression in schizophrenia and bipolar disorder,” PLoS ONE, vol. 6, no. 5, Article ID e19955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. D. Folsom and S. H. Fatemi, “The involvement of Reelin in neurodevelopmental disorders,” Neuropharmacology, vol. 68, pp. 122–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Impagnatiello, A. R. Guidotti, C. Pesold et al., “A decrease of reelin expression as a putative vulnerability factor in schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15718–15723, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Chen, R. P. Sharma, R. H. Costa, E. Costa, and D. R. Grayson, “On the epigenetic regulation of the human reelin promoter,” Nucleic Acids Research, vol. 30, no. 13, pp. 2930–2939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Tamura, H. Kunugi, J. Ohashi, and H. Hohjoh, “Epigenetic aberration of the human REELIN gene in psychiatric disorders,” Molecular Psychiatry, vol. 12, no. 6, pp. 593–600, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. R. Grayson, X. Jia, Y. Chen et al., “Reelin promoter hypermethylation in schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 26, pp. 9341–9346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Detich, J. Theberge, and M. Szyf, “Promoter-specific activation and demethylation by MBD2/demethylase,” Journal of Biological Chemistry, vol. 277, no. 39, pp. 35791–35794, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Bönsch, M. Wunschel, B. Lenz, G. Janssen, M. Weisbrod, and H. Sauer, “Methylation matters? Decreased methylation status of genomic DNA in the blood of schizophrenic twins,” Psychiatry Research, vol. 198, no. 3, pp. 533–537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Veldic, H. J. Caruncho, W. S. Liu et al., “DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 348–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kundakovic, Y. Chen, A. Guidotti, and D. R. Grayson, “The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes,” Molecular Pharmacology, vol. 75, no. 2, pp. 342–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Dong, Y. Chen, D. P. Gavin, D. R. Grayson, and A. Guidotti, “Valproate induces DNA demethylation in nuclear extracts from adult mouse brain,” Epigenetics, vol. 5, no. 8, pp. 730–735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Levenson, “DNA (cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia,” Molecular Pharmacology, vol. 71, no. 3, pp. 635–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Harrison and D. R. Weinberger, “Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence,” Molecular Psychiatry, vol. 10, no. 1, pp. 40–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. H. M. Abdolmaleky, C. L. Smith, S. V. Faraone et al., “Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 127, no. 1, pp. 51–59, 2004. View at Google Scholar · View at Scopus
  28. S. Shifman, M. Johannesson, M. Bronstein et al., “Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women,” PLoS Genetics, vol. 4, no. 2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Lintas and A. M. Persico, “Neocortical RELN promoter methylation increases significantly after puberty,” NeuroReport, vol. 21, no. 2, pp. 114–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Absil, R. Pinxten, J. Balthazart, and M. Eens, “Effects of testosterone on Reelin expression in the brain of male European starlings,” Cell and Tissue Research, vol. 312, no. 1, pp. 81–93, 2003. View at Google Scholar · View at Scopus
  31. M. Ayub and M. J. Levell, “Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue,” Clinical Endocrinology, vol. 32, no. 3, pp. 329–339, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Anahara, Y. Toyama, M. Maekawa et al., “Flutamide depresses expression of cortactin in the ectoplasmic specialization between the Sertoli cells and spermatids in the mouse testis,” Food and Chemical Toxicology, vol. 44, no. 7, pp. 1050–1056, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Anahara, Y. Toyama, and C. Mori, “Review of the histological effects of the anti-androgen, flutamide, on mouse testis,” Reproductive Toxicology, vol. 25, no. 2, pp. 139–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. G. Herman, J. R. Graff, S. Myöhänen, B. D. Nelkin, and S. B. Baylin, “Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9821–9826, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. L.-C. Li and R. Dahiya, “MethPrimer: designing primers for methylation PCRs,” Bioinformatics, vol. 18, no. 11, pp. 1427–1431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Coffee, Methylation-Specific PCR. Current Protocols in Human Genetics, John Wiley & sons, New York, NY, USA, 2009.
  37. J. Schindelin, I. Arganda-Carreras, E. Frise et al., “Fiji: an open-source platform for biological-image analysis,” Nature Methods, vol. 9, no. 7, pp. 676–682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J. C. O'Connor, J. C. Cook, T. W. Slone, G. T. Makovec, S. R. Frame, and L. G. Davis, “An ongoing validation of a tier I screening battery for detecting endocrine-active compounds (EACs),” Toxicological Sciences, vol. 46, no. 1, pp. 46–60, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-Y. Lin, C.-C. Hsu, M.-T. Lin, and S.-H. Chen, “Flutamide, an androgen receptor antagonist, improves heatstroke outcomes in mice,” European Journal of Pharmacology, vol. 688, no. 1–3, pp. 62–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Anahara, Y. Toyama, M. Maekawa et al., “Anti-estrogen ICI 182.780 and anti-androgen flutamide induce tyrosine phosphorylation of cortactin in the ectoplasmic specialization between the Sertoli cell and spermatids in the mouse testis,” Biochemical and Biophysical Research Communications, vol. 346, no. 1, pp. 276–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. L. C. Farias, C. C. Gomes, M. C. Rodrigues et al., “Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma,” BMC Clinical Pathology, vol. 12, article 11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Okazaki, A. Ootsuyama, Y. Yoshida, and T. Norimura, “Establishment of methylation-specific PCR for the mouse p53 gene,” Molecular Biology International, vol. 2011, Article ID 938435, 4 pages, 2011. View at Publisher · View at Google Scholar
  43. L. A. M. Galea, “Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents,” Brain Research Reviews, vol. 57, no. 2, pp. 332–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J.-R. Chen, T.-J. Wang, S.-H. Lim, Y.-J. Wang, and G.-F. Tseng, “Testosterone modulation of dendritic spines of somatosensory cortical pyramidal neurons,” Brain Structure and Function, vol. 218, no. 6, pp. 1407–1417, 2013. View at Publisher · View at Google Scholar · View at Scopus